synthetic genomics
Synbio Company Replay Launches With $55M in Seed Funding
The San Diego and London-based startup aims to tackle gene therapy payload capacity and off-the-shelf cell therapies using its genome medicine technologies.
RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method
Premium
The Watertown, Massachusetts-based firm is looking to develop T cell-based therapies in China, among other applications.
The company, which raised $165 million last month, is collecting feedback from early-access users of its Syntax system at the Broad Institute and elsewhere.
Codexis, Casdin Capital Invest $10M in Molecular Assemblies
The investment is enabled through Codexis and Casdin's SynBio Innovation Accelerator and is part of Molecular Assemblies' ongoing Series B financing round.
The INSIDER algorithm, which grew out of SARS-CoV-2 variant research, looks for shifts in k-mer signatures to streamline the search for novel genomic patterns.